East York, Canada Clinical Trials
A listing of East York, Canada clinical trials actively recruiting patients volunteers.
Found 27 clinical trials
Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer
The primary objective of this study is to evaluate the safety and tolerability of BGT007H cell therapy in patients with recurrent/refractory pancreatic cancer.
- 0 views
- 13 May, 2025
- 1 location
- Online study
A THREE-MONTH CLINICAL STUDY TO ASSESS PARTICIPANT EXPERIENCE, WELLNESS, PHYSIOLOGICAL AND BLOOD BIOMARKERS FOLLOWING DAILY NUTRAMETA™ ADMINISTRATION WITH A THREE-MONTH EXTENSION
This study is evaluating an over-the-counter supplement for weight loss that uses a combination of natural ingredients that have been safely used by humans for hundreds of years. Our research suggests that a unique combination of those ingredients can have a metabolic and neurological benefit if taken over time.
- 0 views
- 03 Sep, 2024
- 1 location
- Online study
The 23andMe Lung Cancer Genetic Study
the lung cancer community and scientists want to learn more about the genetics of people diagnosed with lung cancer and help improve care in the future. While research and targeted therapies have provided hope and progress for many, we still don't know much about the disease and its causes. Your …
- 0 views
- 09 Jan, 2025
- 1 location
- Online study
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
The primary purpose of this study is to determine whether treatment with lecanemab is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Trial) and to determine whether treatment with lecanemab is superior to placebo in reducing brain …
- 0 views
- 10 Jan, 2025
- +105 other locations
A Phase 1/Phase 2 open-label study to evaluate the safety, tolerability, and efficacy of a single intravenous administration of an investigational medication in adult participants with phenylketonuria (PKU)-Tx Tester
This study is looking for individuals 18 to 65 years old with PKU. Sanofi believes that everyoneshould have the opportunity to take part in clinical trials. It is important to include people whohave been historically under-represented in clinical trials. Sanofi is committed to inclusivity inour studies.If you are interested in …
- 0 views
- 23 Dec, 2024
- +7 other locations
A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)
This study will evaluate the efficacy and safety of multiple therapies in participants with locally advanced, unresectable, Stage III NSCLC with eligible biomarker status as determined by Version 8 of the American Joint Committee on Cancer/Union for International Cancer Control NSCLC staging system.
- 0 views
- 10 Jan, 2025
- +134 other locations
Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials
This is a single group, Phase 2, long-term extension study for treatment. The purpose of this study is to characterize the safety and efficacy of amlitelimab in treated adult participants with moderate to severe AD who have previously been enrolled in an amlitelimab clinical trial. Visits during the on-treatment period …
- 0 views
- 03 Dec, 2024
- +79 other locations
Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors
This is Phase 1/Phase 2, open label, multiple cohort, first-in-human study to evaluate safety, PK, PDy and efficacy of SAR444200 as a monotherapy or in combination with other anti-cancer agents for participants aged at least 18 years with previously treated metastatic malignancies.
- 0 views
- 03 Dec, 2024
- +12 other locations
Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura
This is a single group, treatment, Phase 3, open-label, single-arm study to evaluate the efficacy and safety of caplacizumab and immunosuppressive therapy (IST) without firstline therapeutic plasma exchange (TPE) with primary endpoint of remission in male and female participants aged 18 to 80 years with immune-mediated thrombotic thrombocytopenic purpura (iTTP). …
- 0 views
- 16 May, 2024
- +52 other locations
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
This is a single group, 1-arm, long-term safety study for treatment of participants with moderate to severe atopic dermatitis (AD). The purpose of this study is to characterize the long-term safety and efficacy of amlitelimab in treated participants with age ≥12 years old with moderate to severe AD. The study …
- 0 views
- 28 Apr, 2025
- +109 other locations